EUVIMEDEUVIMED entdecken
Crossref

Diffusion-weighted MRI precisely predicts telomerase reverse transcriptase promoter mutation status in World Health Organization grade IV gliomas using a residual convolutional neural network

Congman Hu, Ke Fang, Quan Du, Jiarui Chen, Lin Wang, Jianmin Zhang, Ruiliang Bai, Yongjie Wang iD

British Journal of Radiology · 2024

DOI: 10.1093/bjr/tqae146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Radiology, 2024. Verfasst von Congman Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China. Hauptthemen laut MEDLINE: Glioma, Telomerase, Diffusion Magnetic Resonance Imaging, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Medical Health Science and Technology Project of Zhejiang Province, Clinical Research Center for Neurological Diseases of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Telomerase reverse transcriptase promoter (pTERT) mutation status plays a key role in making decisions and predicting prognoses for patients with World Health Organization (WHO) grade IV glioma. This study was conducted to assess the value of diffusion-weighted imaging (DWI) for predicting pTERT mutation status in WHO grade IV glioma.

Methods

MRI data and molecular information were obtained for 266 patients with WHO grade IV glioma at the hospital and divided into training and validation sets. The ratio of training to validation set was approximately 10:3. We trained the same residual convolutional neural network (ResNet) for each MR modality, including structural MRIs (T1-weighted, T2-weighted, and contrast-enhanced T1-weighted) and DWI*, to compare the predictive capacities between DWI and conventional structural MRI. We also explored the effects of different regions of interest on pTERT mutation status prediction outcomes.

Results

Structural MRI modalities poorly predicted the pTERT mutation status (accuracy = 51%-54%; area under the curve [AUC]=0.545-0.571), whereas DWI combined with its apparent diffusive coefficient maps yielded the best predictive performance (accuracy = 85.2%, AUC = 0.934). Including the radiological and clinical characteristics did not further improve the performance for predicting pTERT mutation status. The entire tumour volume yielded the best prediction performance.

Conclusions

DWI technology shows promising potential for predicting pTERT mutations in WHO grade IV glioma and should be included in the MRI protocol for WHO grade IV glioma in clinical practice. Advances in knowledge This is the first large-scale model study to validate the predictive value of DWI for pTERT in WHO grade IV glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaTelomeraseDiffusion Magnetic Resonance ImagingMutationBrain NeoplasmsPromoter Regions, GeneticNeural Networks, ComputerNeoplasm GradingWorld Health OrganizationHumansFemaleMaleMiddle AgedAdultAgedPredictive Value of TestsRetrospective Studies

Stichwörter der Autor:innen

WHO grade IV gliomasdiffusion MRIneural networktelomerase reverse transcriptase

Substanzen

TelomeraseTERT protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
  • Department of Neurosurgery, Clinical Research Center for Neurological Diseases of Zhejiang Province, Hangzhou 310009, China.
  • Department of Neurosurgery, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu 322000, China.
  • College of Information Science and Electronic Engineering, Zhejiang University, Hangzhou 310020, China.
  • Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
  • Department of Physical Medicine and Rehabilitation of the Affiliated Sir Run Run Shaw Hospital and Interdisciplinary Institute of Neuroscience and Technology, School of Medicine, Zhejiang University, Hangzhou 310020, Ch…

ORCID-Profile: Yongjie Wang

Förderung

  • National Natural Science Foundation of China
  • Medical Health Science and Technology Project of Zhejiang Province
  • Clinical Research Center for Neurological Diseases of Zhejiang Province

Zitieren

APA

Hu, C., Fang, K., Du, Q., Chen, J., Wang, L., Zhang, J., Bai, R., & Wang, Y. (2024). Diffusion-weighted MRI precisely predicts telomerase reverse transcriptase promoter mutation status in World Health Organization grade IV gliomas using a residual convolutional neural network. British Journal of Radiology. https://doi.org/10.1093/bjr/tqae146

Vancouver

Hu C, Fang K, Du Q, Chen J, Wang L, Zhang J, et al. Diffusion-weighted MRI precisely predicts telomerase reverse transcriptase promoter mutation status in World Health Organization grade IV gliomas using a residual convolutional neural network. British Journal of Radiology. 2024. doi:10.1093/bjr/tqae146

BibTeX
@article{Hu2024,
  author = {Hu, Congman and Fang, Ke and Du, Quan and Chen, Jiarui and Wang, Lin and Zhang, Jianmin and Bai, Ruiliang and Wang, Yongjie},
  title = {Diffusion-weighted MRI precisely predicts telomerase reverse transcriptase promoter mutation status in World Health Organization grade IV gliomas using a residual convolutional neural network},
  journal = {British Journal of Radiology},
  year = {2024},
  doi = {10.1093/bjr/tqae146}
}
Kostenlos starten →